INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 188 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,486 | -29.3% | 32,099 | -18.9% | 0.00% | – |
Q2 2023 | $17,663 | -51.5% | 39,558 | -11.0% | 0.00% | – |
Q1 2023 | $36,456 | +1722.8% | 44,458 | +3629.7% | 0.00% | – |
Q3 2022 | $2,000 | -99.7% | 1,192 | -99.4% | 0.00% | -100.0% |
Q1 2022 | $675,000 | +2712.5% | 187,973 | +3744.0% | 0.00% | – |
Q4 2021 | $24,000 | +100.0% | 4,890 | -15.7% | 0.00% | – |
Q3 2019 | $12,000 | -80.6% | 5,803 | -72.4% | 0.00% | -100.0% |
Q2 2019 | $62,000 | -39.2% | 21,005 | -23.1% | 0.00% | 0.0% |
Q1 2019 | $102,000 | +209.1% | 27,305 | +228.0% | 0.00% | – |
Q4 2018 | $33,000 | +10.0% | 8,324 | +53.2% | 0.00% | – |
Q3 2018 | $30,000 | -37.5% | 5,433 | -55.2% | 0.00% | – |
Q2 2018 | $48,000 | -79.1% | 12,120 | -75.2% | 0.00% | -100.0% |
Q1 2018 | $230,000 | +1990.9% | 48,883 | +1668.6% | 0.00% | – |
Q4 2017 | $11,000 | -93.8% | 2,764 | -87.8% | 0.00% | -100.0% |
Q2 2017 | $177,000 | +176.6% | 22,587 | +146.1% | 0.00% | +100.0% |
Q4 2016 | $64,000 | -92.8% | 9,177 | -93.1% | 0.00% | -90.9% |
Q4 2015 | $891,000 | +12.2% | 132,610 | -3.5% | 0.01% | 0.0% |
Q3 2015 | $794,000 | -23.7% | 137,396 | +7.8% | 0.01% | -26.7% |
Q2 2015 | $1,040,000 | +191.3% | 127,431 | +191.0% | 0.02% | +150.0% |
Q1 2015 | $357,000 | -8.0% | 43,797 | +3.5% | 0.01% | 0.0% |
Q4 2014 | $388,000 | -30.0% | 42,307 | -24.8% | 0.01% | -33.3% |
Q3 2014 | $554,000 | – | 56,223 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
Beck Bode, LLC | 41,218 | $33,799 | 0.01% |